| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/02/2004 | CN1151840C Application of interferons(IFN) in preparation of pharmaceutics for tumor of mammal |
| 06/02/2004 | CN1151839C In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide |
| 06/02/2004 | CN1151838C Use of proteins as agents against autoimmune diseases |
| 06/02/2004 | CN1151837C Application of hypermnesia peptide in preparation of medicine for curing menopausal syndrome |
| 06/02/2004 | CN1151836C Compounds and compositions for delivering active agents |
| 06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
| 06/02/2004 | CN1151797C Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/02/2004 | CN1151781C Use of nitric oxide donors or nitric oxide inhibitors for regulation of cervical dilatation and extensibility |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743967 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 06/01/2004 | US6743909 Being 20 to 80 nucleobases in length targeted to 1771 through 1790 of coding region; having at least one modified inter-nucleoside linkage, sugar moiety or nucleobase |
| 06/01/2004 | US6743899 Process for inactivating prions in lipoproteins |
| 06/01/2004 | US6743897 Aspergillus fumigatus profilin |
| 06/01/2004 | US6743895 Bone stimulating factor |
| 06/01/2004 | US6743894 Insulin-like growth factor agonist molecules |
| 06/01/2004 | US6743826 Delivery of compounds having poor water solubility; binding affinity to plasma proteins by way of non-covalent bonds; serum albumin and gamma globulin; paclitaxel, amphotericin b, camptothecin, carbamazepine, cyclosporin a; propofol |
| 06/01/2004 | US6743823 Therapeutic methods relating to human carbamyl phosphate synthetase I polymorphism |
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 06/01/2004 | US6743778 Apo-AI/AII peptide derivatives |
| 06/01/2004 | US6743777 Trisphenyl acyl derivatives of the echinocandin class; candida albicans; antifungal and antiparasitic; cyclic hexapeptides having unique side chain acyl group |
| 06/01/2004 | US6743776 Cyclohexapeptides having antimicrobial activity |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743774 Tribonectins |
| 06/01/2004 | US6743773 Lectins capable of binding sperm and/or the pathogenic microorganisms responsible for std's are administered to the vagina prior to sexual intercourse |
| 06/01/2004 | US6743772 Use of parovirus capsid particles in the inhibition of cell proliferation and migration |
| 06/01/2004 | US6743771 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating alzheimer's disease or creutzfelds-jakob disease for example |
| 06/01/2004 | US6743769 Active against bacteria and fungi that exhibit resistance to multiple current antibiotics; amino acid sequence selected from the group consisting of rp-1 (seq id no: 3), rp-8 (seq id no: 10), rp-11 (seq id no: 13) and rp-13 (seq id no: 14). |
| 06/01/2004 | US6743628 Comprises neuron differentiation growth factor cultures; for treating neurodegenerative disorders |
| 06/01/2004 | US6743627 Using polyamide nucleic acid oligomers to engender a biological response |
| 06/01/2004 | US6743625 Death domain containing receptor 5 |
| 06/01/2004 | US6743613 Nucleotide sequences coding polypeptide for use in the treatment bone and cardiovascular disorders |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743604 Polypeptides binding human il-13 and/or il-4 cytokines used in medicine, diagnosis and screening for agonists/ antagonists of il-13/il-4 |
| 06/01/2004 | US6743594 Identifying antagonists and agonists for diagnosis and therapy |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743435 Processing animal tissues by decellularizing, increasing surface area and acylating |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | US6743429 Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 06/01/2004 | US6743427 Prevention and treatment of amyloidogenic disease |
| 06/01/2004 | US6743426 Administering protein c; avoiding bleeding, toxicity and side effects of anticoagulant agents |
| 06/01/2004 | US6743425 A therapeutic agent for achondroplasia caused by the cartilage growth inhibition resulting from mutations in the gene for fibroblast growth factor receptor 3 comprising a c-type natriuretic peptide activating guanylyl cyclase b |
| 06/01/2004 | US6743424 Method for treating hyperthyroidism |
| 06/01/2004 | US6743422 Protein selected from group consisting of residues 66 through 208 of specified amino acid sequence and residues 66 through 208 of same sequence and n-terminal methionine; stimulates production of epithelial cells |
| 06/01/2004 | US6743417 Topical applying to nails |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | US6743191 Hemofiltration; solution containing ions of dihydrogen phosphate, sodium, calcium, magnesium, potassium, acetate and chloride and glucose |
| 06/01/2004 | CA2295108C Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 06/01/2004 | CA2285058C Coincidence detection method, products and apparatus |
| 06/01/2004 | CA2174231C Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained |
| 06/01/2004 | CA2170605C Mutants of the rb and p53 genes and uses thereof |
| 06/01/2004 | CA2092505C Pharmaceutical compositions containing l-carnitine or an acyl l-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 05/29/2004 | CA2451584A1 Modified cdna factor viii and its derivatives |
| 05/27/2004 | WO2004044592A1 Diagnostic and therapeutic use of arl7 for alzheimer's disease |
| 05/27/2004 | WO2004044591A2 Use of nuclear hormone receptors to identify meiosis regulating compounds |
| 05/27/2004 | WO2004044589A2 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 3 (edg3) |
| 05/27/2004 | WO2004044588A1 Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) |
| 05/27/2004 | WO2004044580A1 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) |
| 05/27/2004 | WO2004044235A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) |
| 05/27/2004 | WO2004044234A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) |
| 05/27/2004 | WO2004044229A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 05/27/2004 | WO2004044226A2 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 05/27/2004 | WO2004044224A2 Branched polymeric prodrugs of vancomycin |
| 05/27/2004 | WO2004044223A2 Prodrugs of vancomycin with hydrolysis resistant polymer linkers |
| 05/27/2004 | WO2004044222A2 Polymeric prodrugs of vancomycin |
| 05/27/2004 | WO2004044220A2 Flaviviris fusion inhibitors |
| 05/27/2004 | WO2004044199A1 Screening method |
| 05/27/2004 | WO2004044196A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) |
| 05/27/2004 | WO2004044194A2 Calmodulin independent activation of nitric oxide synthase by nadph analogs |
| 05/27/2004 | WO2004044192A2 Plasmodium protozoa phosphodiesterase, nucleic acid encoding the phosphodiesterase, and treatment of malaria using inhibitor of the phosphodiesterase |
| 05/27/2004 | WO2004044181A2 Antisense modulation of apolipoprotein b expression |
| 05/27/2004 | WO2004044170A2 A pancreatic islet transcription factor and uses thereof |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044160A2 Muc1 interference rna compositions and methods derived therefrom |
| 05/27/2004 | WO2004044126A2 Novel proteins and their uses |
| 05/27/2004 | WO2004044124A2 Identification of oligoadenylate synthetase-like genes |
| 05/27/2004 | WO2004044006A1 Conjugates of interleukin-10 and polymers |
| 05/27/2004 | WO2004044004A2 T cell receptor display |
| 05/27/2004 | WO2004044002A1 Growth hormone variations in humans and its uses |
| 05/27/2004 | WO2004044001A2 Acetylated hmgb1 protein |
| 05/27/2004 | WO2004044000A2 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | WO2004043996A2 Ligands |
| 05/27/2004 | WO2004043993A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 05/27/2004 | WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors |
| 05/27/2004 | WO2004043886A2 Production of pharmaceutically active proteins in sprouted seedlings |
| 05/27/2004 | WO2004043500A2 Methods for promoting wound healing and uses thereof |
| 05/27/2004 | WO2004043486A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 05/27/2004 | WO2004043485A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 05/27/2004 | WO2004043484A1 Human growth hormone treatment methods |
| 05/27/2004 | WO2004043483A1 A method for treating spinal cord injury |
| 05/27/2004 | WO2004043482A1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser |
| 05/27/2004 | WO2004043481A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | WO2004043480A2 Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa |
| 05/27/2004 | WO2004043479A1 Irrigation solution and method for inhibition of tumor cell adhesion, pain and inflammation |
| 05/27/2004 | WO2004043462A1 Method of treatment of psychological conditions by administration of nerve growth factor |
| 05/27/2004 | WO2004043454A1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents |
| 05/27/2004 | WO2004043442A1 Stable aerosol formulation of peptides and protein with non-cfc propellants |
| 05/27/2004 | WO2004043430A2 Botulinum toxin formulations for oral administration |
| 05/27/2004 | WO2004043428A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |